Galectin Therapeutics Inc
GALT· Nasdaq
Galectin Therapeutics Inc
- Last sale
- Oct 2, 2026 · +3.73%
- Market cap
- $392.31M
- 100.85M shares
- Filings
- 1,012
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $14,290,000 | reported | |
| FY 2024 | 2024-12-31 | $36,571,000 | reported | |
| FY 2023 | 2023-12-31 | $32,130,000 | reported | |
| FY 2022 | 2022-12-31 | $31,737,000 | reported | |
| FY 2021 | 2021-12-31 | $23,818,000 | reported | |
| FY 2020 | 2020-12-31 | $17,976,000 | reported | |
| FY 2019 | 2019-12-31 | $7,467,000 | reported | |
| FY 2018 | 2018-12-31 | $6,471,000 | reported | |
| FY 2017 | 2017-12-31 | $11,721,000 | reported | |
| FY 2016 | 2016-12-31 | $15,325,000 | reported | |
| FY 2015 | 2015-12-31 | $13,114,000 | reported | |
| FY 2014 | 2014-12-31 | $8,425,000 | reported |
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
